Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 4 1Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 9Prostatic Neoplasms 2Neoplasm, Residual 2Lymphoma 2Esophageal Stenosis 2Prostate Cancer Metastatic 1Polycystic Ovary Syndrome 1Myasthenia Gravis 1Metastatic Castration-Resistant Prostate Cancer 1Mediastinal Neoplasms 1Lymphoma, Large-Cell, Anaplastic 1Infertility 1Hodgkin Disease 1Hemangioma 1Esophageal Neoplasms 1Burkitt Lymphoma 1Barrett Esophagus 1Adrenal Insufficiency 1

Interventions

Steroids 1Sirolimus 1Propranolol 1Prednisolone 1Adrenergic beta-Antagonists 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Hemangioma × Prednisolone × Clear all
NCT01908972 2018-12-19

The Safety and Efficiency of Propranolol as an Initial Treatment for Pediatric Hemangioma

Seoul National University Hospital

Phase 4 Completed
34 enrolled 18 charts

Hemangioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡